Clinical Trials

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07555210 2026-05-06

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

BreastDermatologicGenitourinaryHead & NeckThoracic

25 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma, Triple Negative Breast Neoplasms

NCT07525869 2026-04-20

An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

Triple Negative Breast Neoplasms

NCT07513311 2026-04-09

RESTORE

75 enrolled

Triple Negative Breast Neoplasms

NCT07498400 2026-03-27

Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer

216 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07484776 2026-03-20

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Triple Negative Breast Neoplasms

NCT04030507 2026-03-19

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

214 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

BreastGenitourinaryGynecologic

800 enrolled

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT07478705 2026-03-17

EINSTEIN-TNBC

30 enrolled

Recurrence, Triple Negative Breast Neoplasms

NCT05309655 2026-03-16

CROWN

90 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02455791 2026-03-09

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery

43 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02945579 2026-03-09

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

120 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07136493 2026-03-05

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

Phase NA Suspended

350 enrolled

Triple Negative Breast Neoplasms

NCT02993068 2026-02-19

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Phase NA Suspended

5,200 enrolled

Triple Negative Breast Neoplasms

NCT06744465 2026-02-17

NearWave Optical Molecular Monitoring

15 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05677802 2026-02-11

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Triple Negative Breast Neoplasms

NCT07226102 2026-02-04

Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer

Phase NA Withdrawn

BreastGynecologic

Genital Neoplasms, Female, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03017573 2026-02-03

SCANDARE

BreastGynecologicHead & NeckSarcoma

1,050 enrolled

Uterine Cervical Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms, Sarcoma, Vulvar Neoplasms, Triple Negative Breast Neoplasms

NCT04959474 2026-01-23

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

80 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT02158507 2026-01-22

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

20 enrolled 10 charts

Triple Negative Breast Neoplasms

NCT06225505 2026-01-22

CUPCAKE

450 enrolled

Triple Negative Breast Neoplasms

NCT07357948 2026-01-22

WISH-OMICHIR

150 enrolled

Triple Negative Breast Neoplasms

NCT06962163 2026-01-12

EXIGENCE

12 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06328465 2026-01-06

fREEDOM

145 enrolled

Triple Negative Breast Neoplasms

NCT06418126 2026-01-05

TNBC-RT2023

15 enrolled

Triple Negative Breast Neoplasms

NCT06879704 2026-01-02

PRECISION

115 enrolled

Triple Negative Breast Neoplasms

NCT06349512 2025-12-22

FAP-IT

60 enrolled

Triple Negative Breast Neoplasms

NCT06582615 2025-12-11

MIND-TNBC

60 enrolled

Triple Negative Breast Neoplasms

NCT07258563 2025-12-02

TASTY-steering

201 enrolled

BreastGenitourinary

Testicular Neoplasms, Triple Negative Breast Neoplasms

NCT07066189 2025-10-29

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

160 enrolled

Pathologic Complete Response, Motor Activity, Triple Negative Breast Neoplasms

NCT07187674 2025-09-23

The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

20 enrolled

Triple Negative Breast Neoplasms

NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

128 enrolled

BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms

NCT06505018 2025-09-02

ALTERNATIVE

472 enrolled

Triple Negative Breast Neoplasms

NCT06371274 2025-08-12

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

29 enrolled

Triple Negative Breast Neoplasms

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

798 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05722795 2025-07-09

I-CONIC

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07046455 2025-07-01

Trop-2 Targeted PET Probes in Advanced TNBC

20 enrolled

Triple Negative Breast Neoplasms

NCT05086731 2025-06-17

Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

33 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06975644 2025-05-22

Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

55 enrolled

Triple Negative Breast Neoplasms

NCT06610097 2025-04-23

TNBC Gut Microbiota During Neoadjuvant Treatment

30 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03715959 2025-02-25

Nipple Aspirate Fluid in Detecting Breast Cancer

2 enrolled

Triple Negative Breast Neoplasms

NCT03077776 2025-02-20

TRACERX-TNBC

149 enrolled

Triple Negative Breast Neoplasms

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

128 enrolled 24 charts

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT03881605 2025-01-20

SYMPToM

50 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06782698 2025-01-20

HoPEx-Breast

50 enrolled

Breast Neoplasms, Fatigue, Motor Activity, Triple Negative Breast Neoplasms

NCT02266420 2024-12-03

COCABIO000

151 enrolled

Triple Negative Breast Neoplasms

NCT06497322 2024-07-11

Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment

60 enrolled

Breast Neoplasms, Motor Activity, Triple Negative Breast Neoplasms

NCT06057636 2024-05-10

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

Phase NA Withdrawn

Cancer Pain, Agnosia, Breast Neoplasms, Neoplasm Metastasis, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06281210 2024-02-28

BETTY-CRASY

77 enrolled